Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
The American Journal of Pathology|April 1, 1990
Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cellsV M Elner, R M Strieter, S G Elner, et al.
Biochimica Et Biophysica Acta|December 15, 1994
Further characterization of the gelatinase-containing particles of human neutrophilsF Morel, B Dewald, S Berthier, et al.
Clinical and Experimental Rheumatology|March 1, 1992
Production of neutrophil activating peptide-1 (NAP-1/IL-8) by blood and synovial fluid mononuclear cells from patients with arthritisS Bas, T L Vischer, M Ceska, et al.
The Journal of Investigative Dermatology|July 27, 1999
Enhanced expression of eotaxin and CCR3 in atopic dermatitisN Yawalkar, M Uguccioni, J Schärer, et al.
The Journal of Biological Chemistry|January 17, 1997
Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activationK Rajarathnam, C M Kay, B Dewald, et al.
European Journal of Immunology|March 1, 1993
RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptorsS C Bischoff, M Krieger, T Brunner, et al.
The Journal of Experimental Medicine|February 1, 1994
Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokineC A Dahinden, T Geiser, T Brunner, et al.
The Journal of Biological Chemistry|December 9, 2000
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3P Loetscher, A Pellegrino, J H Gong, et al.
Blood|December 9, 2000
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human plateletsK J Clemetson, J M Clemetson, A E Proudfoot, et al.
Science (New York, N.Y.)|April 1, 1994
Neutrophil activation by monomeric interleukin-8K Rajarathnam, B D Sykes, C M Kay, et al.
Pageof 23